Your search for dabigatran returned 105 results

Risks for ischemic stroke or systemic embolism, major bleeding events lower with DOACs overall as a class versus warfarin

Forty-eight percent of atrial fibrillation (AF) patients, who are at the highest risk of stroke, were not prescribed oral anticoagulant (OAC) medication.

And antithrobotic medications linked to higher rate of hematuria-related events in older adults

According to the findings of a recent study, attorney advertisements appear to influence patients’ decisions on modifying or discontinuing their direct oral anticoagulant (DOAC) medication prior to seeking medical advice.

To identify medications with potential proarrhythmic association.

The new findings were based on data from a pooled analysis of two large U.S. commercial health insurance databases.

This marks the fourth FDA approval for the anticoagulant.

End-stage renal disease patients on dialysis with atrial fibrillation are at high risk for thrombotic complications.

A study published in JAMA reports that anticoagulants, antibiotics, diabetes drugs, and opioids are the most common drug classes related to emergency department visits for adverse drug events in the country.

The main outcomes and measures were intraocular bleeding events and associated risk ratio for NOACs, compared with warfarin.